Survival by active treatment rate (ATR) of district
| District active treatment rate (ATR) and % survival (with 95% confidence intervals given in parentheses) | |||||
|---|---|---|---|---|---|
| Group | Survival time | ATR<42% | ATR=42–48% | ATR=48–54% | ATR=>54% |
| All lung cancer | 6 months | 35 (34 to 36) | 37 (35 to 39) | 38 (36 to 39) | 41 (40 to 42) |
| 12 months | 19 (17 to 20) | 20 (18 to 21) | 21 (20 to 22) | 23 (22 to 24) | |
| 18 months | 12 (11 to 13) | 12 (11 to 13) | 14 (13 to 15) | 14 (14 to 15) | |
| 24 months | 8 (8 to 9) | 9 (8 to 10) | 10 (10 to 11) | 10 (10 to 11) | |
| Confirmed non-small cell | 6 months | 43 (41 to 44) | 46 (43 to 48) | 47 (45 to 49) | 49 (47 to 50) |
| 12 months | 24 (23 to 26) | 26 (24 to 28) | 29 (28 to 31) | 29 (28 to 30) | |
| 18 months | 17 (15 to 18) | 17 (15 to 19) | 21 (19 to 22) | 19 (18 to 21) | |
| 24 months | 13 (11 to 14) | 13 (12 to 15) | 16 (15 to 17) | 15 (14 to 16) | |